Physician profile
Ronald J Kim
NPI 1447451554
$14,573.87
in general payments reported to CMS, 2019-2025
65 companies · $3,828 in 2025
The $3,828 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,244 · 2020: $2,116 · 2021: $1,581 · 2022: $1,993 · 2023: $1,995 · 2024: $1,817 · 2025: $3,828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,290 · Consulting Fee: $1,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,289.73 |
| Consulting Fee | $1,350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $2,556.89 | 2019-2025 | Provenge |
| Novartis Pharmaceuticals Corporation | $1,603.10 | 2024-2025 | |
| Abbvie INC. | $1,085.90 | 2019-2025 | |
| Janssen Biotech, INC. | $842.99 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Merck Sharp & Dohme LLC | $675.78 | 2020-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Astellas Pharma US INC | $552.67 | 2019-2025 | Xtandi, Padcev |
| Sumitomo Pharma America, INC. | $460.18 | 2023-2025 | Gemtesa, Orgovyx |
| Blue Earth Diagnostics | $452.35 | 2019-2025 | Posluma |
| Rochester Medical Corporation | $426.15 | 2021-2022 | |
| Axonics, INC. | $352.32 | 2020-2024 | Axonics, Bulkamid |
| Procept Biorobotics Corporation | $338.86 | 2020-2025 | Aquabeam System, Aquabeam Robotic System |
| Olympus America INC. | $300.31 | 2021-2024 | Itind System, Soltive, Olympus |
| Teleflex LLC | $298.72 | 2021-2024 | Urolift |
| Antares Pharma, INC. | $290.31 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Bayer Healthcare Pharmaceuticals INC. | $288.01 | 2019-2025 |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $235.38 | 2021-2022 | |
| Intuitive Surgical, INC. | $226.47 | 2023-2025 | Da Vinci Surgical System |
| Pfizer INC. | $217.97 | 2019-2025 | |
| Amgen INC. | $206.77 | 2019-2024 | Prolia |
| Travere Therapeutics, INC. | $200.44 | 2019-2021 | |
| Accord Healthcare, INC. | $198.00 | 2022-2024 | |
| Coloplast Corp | $197.08 | 2021-2025 | Speedicath |
| Urogen Pharma, INC. | $188.14 | 2023-2025 | Jelmyto |
| Boston Scientific Corporation | $180.71 | 2020-2024 | Rezum Generator, Lithovue |
| Tolmar, INC. | $150.03 | 2023-2025 | Eligard, Rubraca, Jatenzo |
| Endo Pharmaceuticals INC. | $142.36 | 2019-2024 | Xiaflex, Aveed |
| Allergan, INC. | $135.68 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $134.66 | 2024-2025 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $110.57 | 2022-2025 | |
| Medtronic, INC. | $107.46 | 2022 | |
| Janssen Scientific Affairs, LLC | $81.47 | 2019 | |
| Neotract INC. | $73.29 | 2019-2020 | |
| Urovant Sciences INC | $70.45 | 2021-2022 | |
| Emd Serono, INC. | $63.96 | 2019-2020 | |
| Zyla Life Sciences, INC. | $59.24 | 2019 | |
| Telix Pharmaceuticals | $59.05 | 2025 | Illuccix |
| Clarus Therapeutics INC. | $58.31 | 2021 | |
| Laborie Medical Technologies Corp. | $57.12 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Alnylam Pharmaceuticals INC. | $55.90 | 2021-2024 | Oxlumo |
| Richard Wolf Medical Instruments Corp. | $54.33 | 2019 | |
| Verity Pharmaceuticals INC. | $53.60 | 2023-2024 | Trelstar |
| Immunitybio, INC. | $52.45 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $51.74 | 2021-2023 | Bard Urinary Drainage Bag |
| Foundation Medicine, INC. | $51.42 | 2021 | |
| Halozyme INC | $50.97 | 2023 | |
| Sun Pharmaceutical Industries INC. | $49.98 | 2024-2025 | |
| Mission Pharmacal Company | $45.32 | 2022-2023 | Uribel |
| Astrazeneca Pharmaceuticals LP | $44.38 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $42.76 | 2020-2021 | |
| Dentsply Ih INC. | $41.00 | 2019 | |
| Davol INC. | $31.51 | 2025 | Arista |
| Agiliti Surgical, INC. | $30.64 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $29.27 | 2022 | |
| Heron Therapeutics, INC. | $28.00 | 2025 | Zynrelef |
| Vertex Pharmaceuticals Incorporated | $27.79 | 2025 | |
| Histosonics, INC. | $26.95 | 2025 | |
| Tempus Ai, INC | $26.52 | 2024 | |
| Pharmaand Gmbh | $21.83 | 2025 | Rubraca |
| Endo USA, INC. | $20.96 | 2024 | Xiaflex |
| Kowa Pharmaceuticals America, INC. | $17.81 | 2023 | Seglentis |
| Mimedx Group, INC. | $15.09 | 2024 | |
| Edap Technomed INC | $12.32 | 2023 | |
| Hollister Incorporated | $12.18 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$340,124.48 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.